Praxis Precision Medicines (PRAX) Accumulated Expenses (2019 - 2026)

Praxis Precision Medicines' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $17.6 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 13.51% year-over-year to $17.6 million; the TTM figure through Mar 2026 stood at $17.6 million (up 13.51% YoY), while the FY2025 annual figure was $35.0 million, up 47.43% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $17.6 million, down from $35.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $35.0 million in Q4 2025, with the low at $7.0 million in Q1 2024.
• The 5-year median for Accumulated Expenses is $15.8 million (2022), against an average of $17.2 million.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses soared 318.75% in 2022, then sank 69.76% in 2023.
• Praxis Precision Medicines' Accumulated Expenses stood at $15.8 million in 2022, then plunged by 53.21% to $7.4 million in 2023, then soared by 220.43% to $23.8 million in 2024, then surged by 47.43% to $35.0 million in 2025, then slumped by 49.62% to $17.6 million in 2026.
• Business Quant data shows PRAX's Accumulated Expenses at $17.6 million in Q1 2026, $35.0 million in Q4 2025, and $21.6 million in Q3 2025.